浆料转化:一种配制非晶固体分散体和充分整合药物和聚合物组分的通用方法。

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Amy Lan Neusaenger, Caroline Fatina, Yichun Shen, Junguang Yu, Lian Yu
{"title":"浆料转化:一种配制非晶固体分散体和充分整合药物和聚合物组分的通用方法。","authors":"Amy Lan Neusaenger, Caroline Fatina, Yichun Shen, Junguang Yu, Lian Yu","doi":"10.1021/acs.molpharmaceut.5c00240","DOIUrl":null,"url":null,"abstract":"<p><p>A solvent-sparing method, called \"slurry conversion\", has been tested as a general approach to preparing amorphous solid dispersions (ASDs). In this method, a solid mixture of a drug and a polymer is stirred in the presence of a small quantity of a solvent, which is subsequently removed. In previous work, the method enabled more complete salt formation between lumefantrine (LMF), a basic antimalarial, with acidic polymers, than the common methods of hot melt extrusion and spray drying, leading to improved physical stability and release. Here, we apply this method to 18 poorly soluble drugs formulated as binary and ternary ASDs. For a rigorous test, the drugs were formulated with a single polymer, poly(acrylic acid) (PAA), under the same condition: room temperature stirring in 1:1 ethanol-dichloromethane at 4:1 solvent/solid ratio. ASDs were prepared for 16 of the 18 drugs at 25% drug loading and 11 at 50% drug loading. The drugs that were not fully amorphized did not dissolve in the default solvent or crystallized during drying. For most drugs, an abrupt \"clearing\" of the slurry occurred during stirring, indicating complete dissolution and amorphization before drying. While clearing did not occur for some drugs (e.g., clofazimine), the product was still fully amorphous, through solvent-mediated conversion. For a basic drug, the degree of protonation by PAA increases smoothly with PAA concentration and is ordered by its basic strength, supporting the conclusion that the method allows the system to reach thermodynamic equilibrium. In addition to binary ASDs, ternary ASDs containing two drugs (LMF and artemether or LMF and artesunate) were successfully prepared to support applications in combination therapies. In these ternary formulations, the protonation of LMF follows the trend established for binary systems. We find that slurry conversion can be scaled up 60-fold from the typical batch size without any difficulties or adverse effect on the structure and properties of the product. Overall, our results demonstrate that slurry conversion is a general, low-cost, and green alternative to conventional methods for manufacturing ASDs where the components are fully integrated.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Slurry Conversion: A General Method for Formulating Amorphous Solid Dispersions and Fully Integrating Drug and Polymer Components.\",\"authors\":\"Amy Lan Neusaenger, Caroline Fatina, Yichun Shen, Junguang Yu, Lian Yu\",\"doi\":\"10.1021/acs.molpharmaceut.5c00240\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A solvent-sparing method, called \\\"slurry conversion\\\", has been tested as a general approach to preparing amorphous solid dispersions (ASDs). In this method, a solid mixture of a drug and a polymer is stirred in the presence of a small quantity of a solvent, which is subsequently removed. In previous work, the method enabled more complete salt formation between lumefantrine (LMF), a basic antimalarial, with acidic polymers, than the common methods of hot melt extrusion and spray drying, leading to improved physical stability and release. Here, we apply this method to 18 poorly soluble drugs formulated as binary and ternary ASDs. For a rigorous test, the drugs were formulated with a single polymer, poly(acrylic acid) (PAA), under the same condition: room temperature stirring in 1:1 ethanol-dichloromethane at 4:1 solvent/solid ratio. ASDs were prepared for 16 of the 18 drugs at 25% drug loading and 11 at 50% drug loading. The drugs that were not fully amorphized did not dissolve in the default solvent or crystallized during drying. For most drugs, an abrupt \\\"clearing\\\" of the slurry occurred during stirring, indicating complete dissolution and amorphization before drying. While clearing did not occur for some drugs (e.g., clofazimine), the product was still fully amorphous, through solvent-mediated conversion. For a basic drug, the degree of protonation by PAA increases smoothly with PAA concentration and is ordered by its basic strength, supporting the conclusion that the method allows the system to reach thermodynamic equilibrium. In addition to binary ASDs, ternary ASDs containing two drugs (LMF and artemether or LMF and artesunate) were successfully prepared to support applications in combination therapies. In these ternary formulations, the protonation of LMF follows the trend established for binary systems. We find that slurry conversion can be scaled up 60-fold from the typical batch size without any difficulties or adverse effect on the structure and properties of the product. Overall, our results demonstrate that slurry conversion is a general, low-cost, and green alternative to conventional methods for manufacturing ASDs where the components are fully integrated.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.molpharmaceut.5c00240\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00240","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

一种称为“浆液转化”的溶剂节约方法已被测试为制备非晶固体分散体(ASDs)的通用方法。在该方法中,药物和聚合物的固体混合物在少量溶剂的存在下搅拌,随后将其除去。在之前的工作中,该方法使碱性抗疟药lumamitine (LMF)与酸性聚合物之间的盐形成更完整,而不是常见的热熔挤出和喷雾干燥方法,从而提高了物理稳定性和释放性。本文将该方法应用于18种配制为二元和三元asd的难溶性药物。为了进行严格的测试,这些药物由单一聚合物聚丙烯酸(PAA)配制,在相同的条件下:在1:1乙醇-二氯甲烷中以4:1的溶剂/固比室温搅拌。18种药物中有16种在25%载药量下制备了asd, 11种在50%载药量下制备了asd。未完全非晶化的药物在干燥过程中没有溶解在默认溶剂中或结晶。对于大多数药物,在搅拌过程中会突然“清除”浆液,这表明在干燥前完全溶解和非晶化。虽然某些药物(如氯法齐明)没有清除,但通过溶剂介导的转化,产品仍然是完全无定形的。对于碱性药物,PAA的质子化程度随着PAA浓度的增加而平稳增加,并根据其碱性强度排序,支持该方法使体系达到热力学平衡的结论。除二元asd外,还成功制备了含有两种药物(LMF和蒿甲醚或LMF和青蒿琥酯)的三元asd,以支持联合治疗的应用。在这些三元体系中,LMF的质子化遵循二元体系中建立的趋势。我们发现,浆料转化可以从典型的批尺寸放大60倍,而不会对产品的结构和性能产生任何困难或不利影响。总的来说,我们的研究结果表明,泥浆转化是一种通用的、低成本的、绿色的替代方法,可以完全集成组件来制造asd。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Slurry Conversion: A General Method for Formulating Amorphous Solid Dispersions and Fully Integrating Drug and Polymer Components.

A solvent-sparing method, called "slurry conversion", has been tested as a general approach to preparing amorphous solid dispersions (ASDs). In this method, a solid mixture of a drug and a polymer is stirred in the presence of a small quantity of a solvent, which is subsequently removed. In previous work, the method enabled more complete salt formation between lumefantrine (LMF), a basic antimalarial, with acidic polymers, than the common methods of hot melt extrusion and spray drying, leading to improved physical stability and release. Here, we apply this method to 18 poorly soluble drugs formulated as binary and ternary ASDs. For a rigorous test, the drugs were formulated with a single polymer, poly(acrylic acid) (PAA), under the same condition: room temperature stirring in 1:1 ethanol-dichloromethane at 4:1 solvent/solid ratio. ASDs were prepared for 16 of the 18 drugs at 25% drug loading and 11 at 50% drug loading. The drugs that were not fully amorphized did not dissolve in the default solvent or crystallized during drying. For most drugs, an abrupt "clearing" of the slurry occurred during stirring, indicating complete dissolution and amorphization before drying. While clearing did not occur for some drugs (e.g., clofazimine), the product was still fully amorphous, through solvent-mediated conversion. For a basic drug, the degree of protonation by PAA increases smoothly with PAA concentration and is ordered by its basic strength, supporting the conclusion that the method allows the system to reach thermodynamic equilibrium. In addition to binary ASDs, ternary ASDs containing two drugs (LMF and artemether or LMF and artesunate) were successfully prepared to support applications in combination therapies. In these ternary formulations, the protonation of LMF follows the trend established for binary systems. We find that slurry conversion can be scaled up 60-fold from the typical batch size without any difficulties or adverse effect on the structure and properties of the product. Overall, our results demonstrate that slurry conversion is a general, low-cost, and green alternative to conventional methods for manufacturing ASDs where the components are fully integrated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信